EUVIMEDEUVIMED entdecken
Crossref

Hypoxia‐Responsive Covalent Organic Framework Nanoplatform for Breast‐Cancer‐Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms

Guoqin Huang, Lianying Zhang, Jiahao Feng, Dan Wu, Libo Wu, Weilun Pan, Yu Jiang, Ming Chen, Jinxiang Chen iD, Pixian Shui

Small · 2025

DOI: 10.1002/smll.202407553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Guoqin Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunotherapy, Metal-Organic Frameworks, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Special Subsidy for Traditional Chinese Medicine Public Health Service, National Natural Science Foundation of China, Natural Science Foundation from Guangdong Science and Technology Department of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Covalent organic frameworks (COFs), known for their exceptional in situ encapsulation and precise release capabilities, are emerging as pioneering drug delivery systems. This study introduces a hypoxia‐responsive COF designed to encapsulate the chemotherapy drug gambogic acid (GA) in situ. Bimetallic gold‐palladium islands were grown on UiO‐66‐NH 2 (UiO) to form UiO@Au‐Pd islands (UAPi), which were encapsulated with GA through COF membrane formation, resulting in a core‐shell structure (UAPiGC). Further modification with hyaluronic acid (HA) created UiO@Au‐Pd islands @GA‐COF@HA (UAPiGCH) for enhanced tumor targeting. In the hypoxic tumor microenvironment, the COF collapses, releasing GA and UAPi, initiating a triple therapeutic response: nanozyme‐catalyzed therapy, near‐infrared II (NIR‐II) mild photothermal therapy (mild‐PTT), and chemotherapy. UAPi exhibits catalase (CAT)‐like and peroxidase (POD)‐like activities, generating oxygen to alleviate hypoxia and reactive oxygen species (ROS) for tumor destruction. GA acts as a chemotherapeutic agent and inhibits heat shock protein 90 (HSP90), enhancing photothermal sensitivity. In vitro and in vivo studies confirm UAPiGCH’s ability to induce pyroptosis, stimulate dendritic cell maturation, and boost T cell infiltration, demonstrating its potential as a precise therapeutic nanoplatform. This strategy integrates multiple therapies into a hypoxia‐responsive system, offering promising applications in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsImmunotherapyMetal-Organic FrameworksNanoparticlesHumansAnimalsFemaleXanthonesCell Line, TumorMiceTumor MicroenvironmentReactive Oxygen Species

Stichwörter der Autor:innen

NIR‐II mild‐PTTcocktail therapyhypoxia‐responsive COFin situ encapsulationtriple therapeutic response

Substanzen

gambogic acidMetal-Organic FrameworksXanthonesReactive Oxygen Species

Autor:innen und Institutionen

  • School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, and G…
  • The People's Hospital of Gaozhou, Maoming, 525200, China.

ORCID-Profile: Jinxiang Chen

Förderung

  • Special Subsidy for Traditional Chinese Medicine Public Health Service
  • National Natural Science Foundation of China
  • Natural Science Foundation from Guangdong Science and Technology Department of China
  • Science and Technology Program of Guangzhou
  • Animal Ethics Committee of Southern Medical University
  • YangZhou Municipal Science and Technology Bureau

Zitieren

APA

Huang, G., Zhang, L., Feng, J., Wu, D., Wu, L., Pan, W., Jiang, Y., Chen, M., Chen, J., & Shui, P. (2025). Hypoxia‐Responsive Covalent Organic Framework Nanoplatform for Breast‐Cancer‐Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms. Small. https://doi.org/10.1002/smll.202407553

Vancouver

Huang G, Zhang L, Feng J, Wu D, Wu L, Pan W, et al. Hypoxia‐Responsive Covalent Organic Framework Nanoplatform for Breast‐Cancer‐Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms. Small. 2025. doi:10.1002/smll.202407553

BibTeX
@article{Huang2025,
  author = {Huang, Guoqin and Zhang, Lianying and Feng, Jiahao and Wu, Dan and Wu, Libo and Pan, Weilun and Jiang, Yu and Chen, Ming and Chen, Jinxiang and Shui, Pixian},
  title = {Hypoxia‐Responsive Covalent Organic Framework Nanoplatform for Breast‐Cancer‐Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202407553}
}
Kostenlos starten →